Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
World
The Bamboo Works

AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt

Key takeaways:

  • Vaccine maker AIM has filed for an IPO in Hong Kong, following unsuccessful previous bids in Hong Kong and on Shenzhen’s ChiNext board
  • The company has three Covid vaccines under development, including an mRNA vaccine expected to hit the market in the fourth quarter
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.